Nina Massey reports for The Independent:
“A psychedelic drug that gives trips lasting half an hour improves the symptoms of moderate to severe depression for up to six months, early trial results suggest.
Biotechnology company Small Pharma announced the results of its phase 2a clinical trials of the effects of a pharmaceutical-grade formulation of Dimethyltryptamine (SPL026) on major depressive disorder, simply referred to as depression.
The drug is a powerful hallucinogenic found in several plants and can be smoked, snorted or mixed with ayahuasca.
These data indicate that SPL026 can elicit a fast-acting antidepressant response that appears to be enduring in several cases
In the study, 34 patients were given the drug during a clinical session with supportive therapy …”
You can read more from here.
